| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Delong Mark Jeffrey76 | Chief Business &Strat Officer | Sell | 9,913 | $56.90 | $564,049.70 | -15.3% | -28.3% | -56.6% | |
| Mar 15, 2024 | Chopas James George80 | Vp/ Chief Accounting Officer | Sell | 184 | $56.46 | $10,388.82 | -0.5% | -25.0% | -56.5% | |
| Mar 13, 2024 | Nicholson Nur82 | Chief Technical Officer | Sell | 11,220 | $57.56 | $645,837.62 | -8.8% | -25.5% | -57.5% | |
| Mar 8, 2024 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 69,107 | $62.19 | $4,297,549.18 | -2.0% | -33.4% | -59.4% | |
| Mar 1, 2024 | Francois Cedric78 | Chief Executive Officer | Sale+OE | 250,000 | $64.11 | $16,028,705.81 | -10.7% | -36.2% | -60.6% | |
| Mar 1, 2024 | Sullivan Timothy Eugene85 | Chief Financial Officer | Sale+OE | 6,000 | $63.22 | $379,340.00 | -3.1% | -36.2% | -60.6% | |
| Feb 12, 2024 | Watson David O.70 | General Counsel | Sell | 781 | $67.77 | $52,925.95 | -0.7% | -36.5% | -57.9% | |
| Feb 12, 2024 | Townsend Adam J.74 | Chief Commercial Officer | Sell | 1,148 | $67.77 | $77,796.40 | -1.2% | -36.5% | -57.9% | |
| Feb 12, 2024 | Sullivan Timothy Eugene85 | Chief Financial Officer | Sell | 1,431 | $67.77 | $96,974.43 | -1.5% | -36.5% | -57.9% | |
| Feb 12, 2024 | Francois Cedric78 | Chief Executive Officer | Sell | 3,962 | $67.77 | $268,492.46 | -1.2% | -36.5% | -57.9% |